Faster global financial news!
Gujarat Themis Biosyn Ltd., an Indian pharmaceutical company, has secured private credit funding to acquire its Japanese counterpart, MicroBiopharm Japan Co.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Citadel Securities has poached Matthew Zimmerman from Diameter Capital Partners to head investment-grade corporate bond trading.
-
2
What is RCN coin? Where to trade and buy RCN coin?
-
3
What is HNW coin? Where can HNW coin be traded and bought?
-
4
September Ethereum Price Outlook: Can Polymarket's $2,600 Target Be Achieved?
-
5
What is BFT token? Can BFT token be held for the long term?
-
6
How Will BlackRock's Staked Ethereum ETF Impact the Ethereum Ecosystem on Its First Day with $15.5 Million in Inflows?
-
7
What is the value of OLIVE coin? Is OLIVE coin a good long-term investment?
-
8
CNBC: NVIDIA Drops 11% This Week, While AMD, Broadcom, and TSMC Rise
-
9
Al Jazeera, citing Iranian media: Iranian Navy claims to have shot down US MQ-1 drone in Strait of Hormuz
-
10
Chinese stocks led a rally in Asian chip shares as investors shrugged off the NVIDIA controversy surrounding Jensen Huang and rushed back into AI trades.
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
